Skip to main content
HCPCS J7321 · Level II · Part B drug

J7321: hyaluronan or derivative (Visco-3, Hyalgan, Supartz FX), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J7321

Billing unit
per dose
Hyalgan supartz visco-3 dose
ASP payment limit
$69.868
October 2026; -0.6% vs July 2026
Practitioner MUE
2
MAI 2
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
3
13 states

TL;DR

HCPCS J7321 is the Level II code for Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose, billed per per dose. The Medicare Part B ASP payment limit for October 2026 is $69.868 per billing unit, down 0.6% from July 2026. The practitioner MUE allows up to 2 units per date of service (MAI 2), so a full 2-unit day is $139.74 at the current limit. Under OPPS it carries status indicator N. Site-specific administration routes in the descriptor tie the drug to a particular procedure code; the pairing is where NCCI column-1/column-2 edits and modifier decisions arise. Other HCPCS codes whose descriptor names hyaluronan or derivative: J7323 (Euflexxa from Ferring Pharmaceuticals Inc); J7326 (Gel-One); J7322 (CMS descriptor names "hymovis or hymovis one"; billed per 1 mg); J7318 (Durolane; billed per 1 mg); J7324 (Orthovisc from DePuy Synthes Sales, Inc.; billed per dose); J7325 (CMS descriptor names "synvisc or synvisc-one"; billed per 1 mg). The ASP crosswalk maps 4 NDCs to it, sold as Visco-3, Hyalgan, Supartz FX by Zimmer Biomet, Fidia Pharma USA Inc, Bioventus LLC. 3 Medicare coverage articles list the code across 13 states, including A52420.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J7321 at $69.868 per per dose for October 2026, derived from manufacturer average sales price plus 6%, compared with $70.282 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J7321
QuarterPayment limitPerCoinsurance
October 2026$69.868per dose20%
July 2026$70.282per dose—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 4 NDCs from 3 labelers to J7321. Report the NDC in the claim's drug segment and bill the number of J7321 units that equals the quantity administered divided by per dose; the last column gives units per full package.

NDCs that crosswalk to J7321
NDCDrug nameLabelerPackage sizeBilling units / package
50016-0957-21Visco-3Zimmer Biomet2.5 × 33
89122-0724-12HyalganFidia Pharma USA Inc2 × 11
89122-0724-20HyalganFidia Pharma USA Inc2 × 11
89130-4444-01Supartz FXBioventus LLC2.5 × 11

Medically Unlikely Edits (MUE)

CMS publishes 2 MUE values for J7321. For practitioners the limit is 2 units per date of service with adjudication indicator 2, a date-of-service policy edit: the limit reflects CMS policy and units above it deny even if split across lines; appeals rarely succeed.

MUE values for J7321 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services22 Date of Service Edit: PolicyAnatomic Consideration
Facility outpatient hospital22 Date of Service Edit: PolicyAnatomic Consideration

MUE for J7321 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J7321 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J7321 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J7321 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

3 current Medicare Administrative Contractor articles list J7321 in their HCPCS tables, covering 13 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J7321
ArticleTitleContractor(s)StatesRelated LCD
A52420Billing and Coding: Hyaluronans Intra-articular Injections ofWellpoint FederalCT IL MN NY WIL33394
A56157Billing and Coding: Intraarticular Knee Injections of HyaluronanWisconsin Physicians Service Insurance CorporationIA KS MO NEL39529
A59030Billing and Coding: Hyaluronic Acid Injections for Knee OsteoarthritisPalmetto GBANC SC VA WVL39260

Diagnoses Medicare contractors cover for J7321

3 billing and coding articles attach a covered diagnosis list to J7321: 17 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J7321
ICD-10-CMDescription (FY2027)Articles covering
M17.0Bilateral primary osteoarthritis of knee3 of 3
M17.11Unilateral primary osteoarthritis, right knee3 of 3
M17.12Unilateral primary osteoarthritis, left knee3 of 3
M17.2Bilateral post-traumatic osteoarthritis of knee3 of 3
M17.31Unilateral post-traumatic osteoarthritis, right knee3 of 3
M17.32Unilateral post-traumatic osteoarthritis, left knee3 of 3
M17.4Other bilateral secondary osteoarthritis of knee3 of 3
M17.5Other unilateral secondary osteoarthritis of knee3 of 3
M17.9Osteoarthritis of knee, unspecified1 of 3
M19.011Primary osteoarthritis, right shoulder1 of 3
M19.012Primary osteoarthritis, left shoulder1 of 3
M19.111Post-traumatic osteoarthritis, right shoulder1 of 3
M19.112Post-traumatic osteoarthritis, left shoulder1 of 3
M19.211Secondary osteoarthritis, right shoulder1 of 3
M19.212Secondary osteoarthritis, left shoulder1 of 3
2 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J7321 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J7321, by article
ArticleContractorGroups that applyCovered codes for J7321Full list
A52420Wellpoint Federalone list for every code in the article17On LCD L33394
A56157Wisconsin Physicians Service Insurance Corporationone list for every code in the article8On LCD L39529
A59030Palmetto GBAone list for every code in the article8On LCD L39260

Local coverage policies that list J7321

3 active Local Coverage Determinations list J7321 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J7321 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J7321 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J7321 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J7321

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J7321

What does HCPCS code J7321 describe?

J7321 is defined by CMS as "Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose". Each billing unit represents per dose, so the units reported on the claim must equal the dose administered divided by that unit.

Is J7321 a CPT code?

No. J7321 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as hyaluronan or derivative; CPT codes are five-character codes maintained by the AMA. On a Part B claim J7321 reports the drug itself in per dose units, and the administration is billed on its own line.

What is the Medicare reimbursement for J7321 in October 2026?

The ASP-based payment limit is $69.868 per per dose, with 20% beneficiary coinsurance. The July 2026 limit was $70.282. Commercial payers use their own fee schedules.

How many units of J7321 can be billed per day?

The practitioner Medically Unlikely Edit is 2 units per date of service with adjudication indicator 2 (Date of Service Edit: Policy). MAI 2 edits are policy limits and are rarely overturned on appeal. CMS cites "Anatomic Consideration" as the rationale.

Which NDCs map to J7321?

The October 2026 ASP crosswalk lists 4 NDCs from 3 labelers: Visco-3 (Zimmer Biomet); Hyalgan (Fidia Pharma USA Inc); Supartz FX (Bioventus LLC). For example NDC 50016-0957-21 (package size 2.5) equals 3 billing units of J7321.

Does J7321 have NCCI bundling edits?

No active practitioner PTP pairs list J7321 as a column-1 or column-2 code in the v323r0 release.

J7321 vs J7323: what is the difference?

Both are HCPCS Level II codes whose descriptor names hyaluronan or derivative. What sets J7323 apart: Euflexxa from Ferring Pharmaceuticals Inc. J7321 is billed per per dose, limit $69.868, MUE 2; J7323 is billed per per dose, limit $103.603, MUE 2. Report the code whose descriptor matches the product and setting in the record.

J7321 vs J7326: what is the difference?

Both are HCPCS Level II codes whose descriptor names hyaluronan or derivative. What sets J7326 apart: Gel-One. J7321 is billed per per dose, limit $69.868, MUE 2; J7326 is billed per per dose, limit $524.063, MUE 2. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J7321?

3 current Billing and Coding Articles in the Medicare Coverage Database list J7321, covering 13 states: A52420 (Billing and Coding: Hyaluronans Intra-articular Injections of); A56157 (Billing and Coding: Intraarticular Knee Injections of Hyaluronan); A59030 (Billing and Coding: Hyaluronic Acid Injections for Knee Osteoarthritis).

What diagnosis codes support J7321?

3 Medicare billing and coding articles list 17 covered ICD-10-CM codes for J7321 between them, for example M17.0 (Bilateral primary osteoarthritis of knee); M17.11 (Unilateral primary osteoarthritis, right knee); M17.12 (Unilateral primary osteoarthritis, left knee); M17.2 (Bilateral post-traumatic osteoarthritis of knee); M17.31 (Unilateral post-traumatic osteoarthritis, right knee). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.